6-Gingerol reshapes exosomal miR-148b-3p/ACSL4 axis to combat high glucose-induced retinal endothelial ferroptosis

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Diabetic retinopathy (DR), a leading cause of blindness, is driven by redox imbalance and ferroptosis in retinal endothelial cells. While 6-Gingerol exhibits antioxidant properties, its role in modulating exosome-mediated redox signaling in DR remains unexplored.This study investigates whether 6-Gingerol protects against DR by regulating ferroptosis via the exosomal miR-148b-3p/ACSL4 axis. Methods Human retinal microvascular endothelial cells (HRMECs) were exposed to high glucose (HG) ± 6-Gingerol. Ferroptosis was assessed via lipid ROS, intracellular iron, and key markers (GPX4, ACSL4, FTH1). Exosomal miRNAs were profiled by sequencing, with miR-148b-3p validated as a regulator of ACSL4 through luciferase assays. Functional rescue experiments confirmed pathway specificity. Results 6-Gingerol suppressed HG-induced ferroptosis, reducing lipid ROS by 2.1-fold ( P  < 0.01) and iron accumulation by 1.8-fold ( P  < 0.05), while upregulating GPX4 (3.2-fold, P  < 0.001). Exosomal miR-148b-3p was downregulated under HG but restored by 6-Gingerol (4.5-fold, P  < 0.001). miR-148b-3p directly targeted ACSL4, whose knockdown mimicked 6-Gingerol’s effects, whereas ACSL4 overexpression or miR-148b-3p inhibition abolished protection. Conclusions 6-Gingerol mitigates DR progression by inhibiting ferroptosis through exosomal miR-148b-3p/ACSL4-dependent redox regulation. These findings unveil a novel crosstalk between exosomal miRNAs and iron metabolism, positioning 6-Gingerol as a potential redox-targeted therapy for DR.

Article activity feed